Overview
Polypharm is a pharmaceutical wholesaler that offers medicinal products, medical materials, dietary supplements, and cosmetics. The company also imports pharmaceuticals from outside the EU and provides storage services for medicinal products. Additionally, it engages in parallel import of well-known brand medicines at lower prices.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 1996-01-01. Active
06 1240 1024 1111 0000 0268 1588- 13 1240 1024 1111 0000 0268 1559
- 18 1240 1024 1978 0000 0268 1575
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $298.9K$298,946 |
Buildings and premises | $1.8M$1,818,238 |
Public aid
7 public aid cases recorded, with a total value of $50,564.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 30, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $5,077$5,077 | Prezes Banku Gospodarstwa Krajowego | |
| Oct 18, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $12,879$12,879 | Prezes Banku Gospodarstwa Krajowego | |
| Oct 22, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $5,470$5,470 | Prezes Banku Gospodarstwa Krajowego |
Tenders
114 tenders recorded as contractor: 82 national ($1,200,703) and 32 EU ($23,516,625).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 13, 2026 | Szczepionka przeciw wirusowemu zapaleniu wątroby typu b dla dorosłych z grup ryzyka, inj. 1,0 ml. Części: 1-4; znak postępowania: ZZP.ZP.411.133.2026 | –– | Ministerstwo Zdrowia | |
| Sep 25, 2026 | Szczepionka przeciw wirusowemu zapaleniu wątroby typu B (WZW typu B) dla dzieci, inj. 0,5 ml. Części: 1-4; znak postępowania: ZZP.ZP.411.132.2026 | –– | Ministerstwo Zdrowia | |
| Sep 14, 2026 | DFP.271.127.2026.AB | –– | Szpital Uniwersytecki w Krakowie |
Public sector contracts
Polypharm is the contractor in 61 public sector contracts, worth PLN 6.28m in total. They were signed with 24 public buyers.
| Public buyer | Value | |
|---|---|---|
| Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza w Bydgoszczy | PLN 30,432 | |
| Ministerstwo Zdrowia | PLN 5,508,000 | |
| Samodzielny Zespół Publicznych Zakładów Lecznictwa Otwartego Warszawa Praga Południe | PLN 155.89 | |
| Samodzielny Zespół Publicznych Zakładów Lecznictwa Otwartego Warszawa Praga Południe | PLN 1,216 | |
| Samodzielny Zespół Publicznych Zakładów Lecznictwa Otwartego Warszawa Praga Południe | PLN 847.62 |
Public procurement disputes (KIO)
Polypharm has been a party to 1 case before the National Appeal Chamber (since 2010). It filed 1 appeal (1 rejected).
Trademarks
Polypharm currently holds no active trademarks with the Polish Patent Office. 6 marks have expired or were not registered. The first mark was filed in 2000.
| Mark | Protected until | |
|---|---|---|
| Kocie Sekrety UNIKALNA TECHNOLOGIA Nowoczesny żwirek dla kotów NATURALNA FORMUŁA ZWIĘKSZONA WCHŁANIALNOŚĆ PRZYSZŁOŚĆ KOCIEJ KUWETY Bez zapachu Bez bryłek Bez śladów Bez problemów 1 Torba 1Kot 1 Miesiąc POLYPharm | – | |
| Avigold | – | |
| Avigold(word) | – | |
| Auripul(word) | – | |
| dr + vet | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Individual representation – member of the management board.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biuro Handlowe Elroy Krystyna Maria Rojek Leszek Michał Rojeksp. j. | $23,394,384.27 | elroy.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Midas Pharma Polskasp. z o.o. | $20,847,894.51 | midas-pharma.com | ||
| Livistosp. z o.o. | $17,956,135.04 | livisto.pl | ||
| OwlieS.A. | $17,199,251.89 | owlie.pl | ||
| Biochem PolskaS.A. | $13,180,007.81 | biochempolska.pl | ||
| Nutropharmasp. z o.o. | $13,240,122.91 | nutropharma.pl | ||
| Prodpolsp. z o.o. | $8,498,232.41 | prodpol.pl | ||
| Euroleki Gksp. z o.o. + limited partnership | $6,866,421.91 | euroleki.eu | ||
| Bestpharmasp. z o.o. | $5,786,190.68 | bestpharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-30 | Address change (Barska 33, 02-315, Warszawa → Ul. Julianowska 41, 05-500, Piaseczno) | |
| 2003-04-15 | Share capital change (500,000.00 PLN → 1,000,000.00 PLN) | |
| 2001-10-12 | Entered in the register |
FAQ
Last updated: 2026-04-02